- Medicine Name: Lorbrena
- Generic Name: Lorlatinib
- Dosage Form & Strength: Tablets: 25 mg or 100 mg
- Manufactured By: Pfizer Inc
Lorbrena is a kinase inhibitor used for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive.
Recommended Dosage: The recommended dosage of Lorbrena Tablets is 100 mg taken orally once daily, with or without food, until the disease is progressive or unacceptable toxicity occurs. Swallow tablets completely. It is not advisable to chew, crush or split them. Do not ingest in case the tablets are broken, cracked, or otherwise not intact.
Take this medicine persistently each day. In case a dose is missed, then take the missed dose unless the next dose is due within four hours. Do not take a couple of doses at the same time in order to make up for a missed dose. Do not take any additional dose in case vomiting occurs after dosage but continue with the very next scheduled dose.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.